“…Therefore, cardiac denervation alters cardiovascular control in HTx recipients . It results in lower cardiac index (CI) and heart rate variability (HRV) or heart period variability (HPV), abnormal chronotropic response to exercise, abnormal catecholamine release and hemodynamic responses to exercise and tyramine injection, impaired exercise capacity and physical function, altered diastolic function of the ventricles, presynaptic inotropic supersensitivity and lower inotropic reserve, higher resting HR due to the lack of parasympathetic vagal efferent nerve connections, higher stroke volume (SV), temporary sinus node dysfunction, abnormal cardiopulmonary baroreflexes, depletion of cardiac norepinephrine (NE) within the nerve terminals, higher sensitivity to circulating endogenous CAT due to the lack of presynaptic neuronal uptake capacity which may increase the frequency of arrhythmias, and altered response to adrenergic drugs, which requires adjustments to pharmacotherapy in HTx recipients …”